English
简体中文
Total: £ 56.28
Published Date: 2025-07-10 | Pages: 82 | Tables: 82 | Pharma & Healthcare
The global market for Nifedipine Controlled-release Tablets was valued at US$ 925 million in the year 2024 and is projected to reach a revised size of US$ 1093 million by 2031, growing at a CAGR of 2.2% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nifedipine Controlled-release Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Nifedipine Controlled-release Tablets, also known as Nifedipine Gastrointestinal Therapeutic System (GITS), are an advanced extended-release antihypertensive formulation commonly available in 30mg per tablet. The system is based on an osmotic pump design, comprising a drug-containing layer and an osmotically active push layer, all enclosed in a semi-permeable membrane and protective coating. After ingestion, the push layer absorbs gastrointestinal fluid and swells, gradually forcing the drug through a precision laser-drilled orifice. This enables a slow and sustained release of the active ingredient, helping maintain stable blood drug levels for effective management of hypertension or angina, while reducing dosing frequency and improving patient compliance.
Nifedipine controlled-release tablets have been widely used for the treatment of hypertension and angina for many years in both domestic and international markets. Compared to conventional tablets, their sustained-release mechanism helps minimize blood pressure fluctuations, reduce side effects, and improve patient adherence, making them particularly suitable for long-term management of moderate to severe hypertension. In China, the market is dominated by generics, with some formulations adopting advanced imported technologies like the GITS osmotic pump system, ensuring stable efficacy and pharmacokinetics. These formulations are well covered by medical insurance and are commonly prescribed across tertiary hospitals and primary healthcare settings.With the continued rise in hypertension prevalence and an aging population, alongside growing awareness of chronic disease management, demand for safe, long-acting, and patient-friendly antihypertensive drugs will remain strong. Nifedipine controlled-release tablets are well positioned to benefit from this trend. As centralized procurement policies expand and generic consistency evaluations become standard, manufacturers with advanced formulation technologies are expected to stand out. Future product development will likely focus on diversified specifications and dosage forms to meet personalized treatment needs. Innovations in delivery platforms—such as updated osmotic systems, microneedles, or mucoadhesive formulations—are also being explored to enhance controlled-release performance and market differentiation.Key drivers include a strong balance between efficacy and safety, endorsement in clinical guidelines, wide insurance coverage, and alignment with chronic disease care models. These tablets significantly improve adherence in long-term therapy and play an important role in grassroots hypertension control programs. However, challenges exist: proprietary controlled-release technologies such as GITS present high entry barriers, and some generics struggle to fully replicate the reference release profile. Meanwhile, aggressive price cuts under centralized procurement have compressed profit margins, increasing pressure on small- to mid-sized manufacturers. Additionally, competition from newer calcium channel blockers and combination therapies poses a risk of substitution in certain clinical application.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nifedipine Controlled-release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nifedipine Controlled-release Tablets.
The Nifedipine Controlled-release Tablets market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nifedipine Controlled-release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nifedipine Controlled-release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bayer
Shanghai Shyndec Pharmaceutical
Beijing Honglin Pharma
Nanjing Easeheal Pharmaceutical
Qingdao BAHEAL Pharmaceutical
Simcere Pharmaceutical
Hefei Lifeon Pharmaceutical
China Resources Double-Crane Pharmaceutical
CSPC Ouyi Pharmaceutical
ApicHope Pharmaceutical
Segment by Type
Generic Drug
Original Drug
Segment by Application
Hypertension
Coronary Heart Disease
Chronic Stable Angina
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nifedipine Controlled-release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nifedipine Controlled-release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Nifedipine Controlled-release Tablets Market Overview
1.1 Product Definition
1.2 Nifedipine Controlled-release Tablets by Type
1.2.1 Global Nifedipine Controlled-release Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Nifedipine Controlled-release Tablets by Application
1.3.1 Global Nifedipine Controlled-release Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hypertension
1.3.3 Coronary Heart Disease
1.3.4 Chronic Stable Angina
1.3.5 Other
1.4 Global Nifedipine Controlled-release Tablets Market Size Estimates and Forecasts
1.4.1 Global Nifedipine Controlled-release Tablets Revenue 2020-2031
1.4.2 Global Nifedipine Controlled-release Tablets Sales 2020-2031
1.4.3 Global Nifedipine Controlled-release Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nifedipine Controlled-release Tablets Market Competition by Manufacturers
2.1 Global Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nifedipine Controlled-release Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nifedipine Controlled-release Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nifedipine Controlled-release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nifedipine Controlled-release Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nifedipine Controlled-release Tablets, Product Type & Application
2.7 Global Key Manufacturers of Nifedipine Controlled-release Tablets, Date of Enter into This Industry
2.8 Global Nifedipine Controlled-release Tablets Market Competitive Situation and Trends
2.8.1 Global Nifedipine Controlled-release Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nifedipine Controlled-release Tablets Players Market Share by Revenue
2.8.3 Global Nifedipine Controlled-release Tablets Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nifedipine Controlled-release Tablets Market Scenario by Region
3.1 Global Nifedipine Controlled-release Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nifedipine Controlled-release Tablets Sales by Region: 2020-2031
3.2.1 Global Nifedipine Controlled-release Tablets Sales by Region: 2020-2025
3.2.2 Global Nifedipine Controlled-release Tablets Sales by Region: 2026-2031
3.3 Global Nifedipine Controlled-release Tablets Revenue by Region: 2020-2031
3.3.1 Global Nifedipine Controlled-release Tablets Revenue by Region: 2020-2025
3.3.2 Global Nifedipine Controlled-release Tablets Revenue by Region: 2026-2031
3.4 North America Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.4.1 North America Nifedipine Controlled-release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nifedipine Controlled-release Tablets Sales by Country (2020-2031)
3.4.3 North America Nifedipine Controlled-release Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.5.1 Europe Nifedipine Controlled-release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nifedipine Controlled-release Tablets Sales by Country (2020-2031)
3.5.3 Europe Nifedipine Controlled-release Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nifedipine Controlled-release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Nifedipine Controlled-release Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nifedipine Controlled-release Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Nifedipine Controlled-release Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.7.1 Latin America Nifedipine Controlled-release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nifedipine Controlled-release Tablets Sales by Country (2020-2031)
3.7.3 Latin America Nifedipine Controlled-release Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Nifedipine Controlled-release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nifedipine Controlled-release Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nifedipine Controlled-release Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nifedipine Controlled-release Tablets Sales by Type (2020-2031)
4.1.1 Global Nifedipine Controlled-release Tablets Sales by Type (2020-2025)
4.1.2 Global Nifedipine Controlled-release Tablets Sales by Type (2026-2031)
4.1.3 Global Nifedipine Controlled-release Tablets Sales Market Share by Type (2020-2031)
4.2 Global Nifedipine Controlled-release Tablets Revenue by Type (2020-2031)
4.2.1 Global Nifedipine Controlled-release Tablets Revenue by Type (2020-2025)
4.2.2 Global Nifedipine Controlled-release Tablets Revenue by Type (2026-2031)
4.2.3 Global Nifedipine Controlled-release Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Nifedipine Controlled-release Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nifedipine Controlled-release Tablets Sales by Application (2020-2031)
5.1.1 Global Nifedipine Controlled-release Tablets Sales by Application (2020-2025)
5.1.2 Global Nifedipine Controlled-release Tablets Sales by Application (2026-2031)
5.1.3 Global Nifedipine Controlled-release Tablets Sales Market Share by Application (2020-2031)
5.2 Global Nifedipine Controlled-release Tablets Revenue by Application (2020-2031)
5.2.1 Global Nifedipine Controlled-release Tablets Revenue by Application (2020-2025)
5.2.2 Global Nifedipine Controlled-release Tablets Revenue by Application (2026-2031)
5.2.3 Global Nifedipine Controlled-release Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Nifedipine Controlled-release Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Nifedipine Controlled-release Tablets Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Shanghai Shyndec Pharmaceutical
6.2.1 Shanghai Shyndec Pharmaceutical Company Information
6.2.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.2.3 Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.2.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.3 Beijing Honglin Pharma
6.3.1 Beijing Honglin Pharma Company Information
6.3.2 Beijing Honglin Pharma Description and Business Overview
6.3.3 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product Portfolio
6.3.5 Beijing Honglin Pharma Recent Developments/Updates
6.4 Nanjing Easeheal Pharmaceutical
6.4.1 Nanjing Easeheal Pharmaceutical Company Information
6.4.2 Nanjing Easeheal Pharmaceutical Description and Business Overview
6.4.3 Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.4.5 Nanjing Easeheal Pharmaceutical Recent Developments/Updates
6.5 Qingdao BAHEAL Pharmaceutical
6.5.1 Qingdao BAHEAL Pharmaceutical Company Information
6.5.2 Qingdao BAHEAL Pharmaceutical Description and Business Overview
6.5.3 Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.5.5 Qingdao BAHEAL Pharmaceutical Recent Developments/Updates
6.6 Simcere Pharmaceutical
6.6.1 Simcere Pharmaceutical Company Information
6.6.2 Simcere Pharmaceutical Description and Business Overview
6.6.3 Simcere Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Simcere Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.6.5 Simcere Pharmaceutical Recent Developments/Updates
6.7 Hefei Lifeon Pharmaceutical
6.7.1 Hefei Lifeon Pharmaceutical Company Information
6.7.2 Hefei Lifeon Pharmaceutical Description and Business Overview
6.7.3 Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.7.5 Hefei Lifeon Pharmaceutical Recent Developments/Updates
6.8 China Resources Double-Crane Pharmaceutical
6.8.1 China Resources Double-Crane Pharmaceutical Company Information
6.8.2 China Resources Double-Crane Pharmaceutical Description and Business Overview
6.8.3 China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.8.5 China Resources Double-Crane Pharmaceutical Recent Developments/Updates
6.9 CSPC Ouyi Pharmaceutical
6.9.1 CSPC Ouyi Pharmaceutical Company Information
6.9.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.9.3 CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.9.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.10 ApicHope Pharmaceutical
6.10.1 ApicHope Pharmaceutical Company Information
6.10.2 ApicHope Pharmaceutical Description and Business Overview
6.10.3 ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
6.10.5 ApicHope Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nifedipine Controlled-release Tablets Industry Chain Analysis
7.2 Nifedipine Controlled-release Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nifedipine Controlled-release Tablets Production Mode & Process Analysis
7.4 Nifedipine Controlled-release Tablets Sales and Marketing
7.4.1 Nifedipine Controlled-release Tablets Sales Channels
7.4.2 Nifedipine Controlled-release Tablets Distributors
7.5 Nifedipine Controlled-release Tablets Customer Analysis
8 Nifedipine Controlled-release Tablets Market Dynamics
8.1 Nifedipine Controlled-release Tablets Industry Trends
8.2 Nifedipine Controlled-release Tablets Market Drivers
8.3 Nifedipine Controlled-release Tablets Market Challenges
8.4 Nifedipine Controlled-release Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Nifedipine Controlled-release Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Nifedipine Controlled-release Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Nifedipine Controlled-release Tablets Market Competitive Situation by Manufacturers in 2024
Table 4. Global Nifedipine Controlled-release Tablets Sales (kg) of Key Manufacturers (2020-2025)
Table 5. Global Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Nifedipine Controlled-release Tablets Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Nifedipine Controlled-release Tablets Average Price (US$/g) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Nifedipine Controlled-release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nifedipine Controlled-release Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nifedipine Controlled-release Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Nifedipine Controlled-release Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nifedipine Controlled-release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nifedipine Controlled-release Tablets as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nifedipine Controlled-release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Nifedipine Controlled-release Tablets Sales by Region (2020-2025) & (kg)
Table 18. Global Nifedipine Controlled-release Tablets Sales Market Share by Region (2020-2025)
Table 19. Global Nifedipine Controlled-release Tablets Sales by Region (2026-2031) & (kg)
Table 20. Global Nifedipine Controlled-release Tablets Sales Market Share by Region (2026-2031)
Table 21. Global Nifedipine Controlled-release Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Nifedipine Controlled-release Tablets Revenue Market Share by Region (2020-2025)
Table 23. Global Nifedipine Controlled-release Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Nifedipine Controlled-release Tablets Revenue Market Share by Region (2026-2031)
Table 25. North America Nifedipine Controlled-release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Nifedipine Controlled-release Tablets Sales by Country (2020-2025) & (kg)
Table 27. North America Nifedipine Controlled-release Tablets Sales by Country (2026-2031) & (kg)
Table 28. North America Nifedipine Controlled-release Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Nifedipine Controlled-release Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Nifedipine Controlled-release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Nifedipine Controlled-release Tablets Sales by Country (2020-2025) & (kg)
Table 32. Europe Nifedipine Controlled-release Tablets Sales by Country (2026-2031) & (kg)
Table 33. Europe Nifedipine Controlled-release Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Nifedipine Controlled-release Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Nifedipine Controlled-release Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Nifedipine Controlled-release Tablets Sales by Region (2020-2025) & (kg)
Table 37. Asia Pacific Nifedipine Controlled-release Tablets Sales by Region (2026-2031) & (kg)
Table 38. Asia Pacific Nifedipine Controlled-release Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Nifedipine Controlled-release Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nifedipine Controlled-release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Nifedipine Controlled-release Tablets Sales by Country (2020-2025) & (kg)
Table 42. Latin America Nifedipine Controlled-release Tablets Sales by Country (2026-2031) & (kg)
Table 43. Latin America Nifedipine Controlled-release Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nifedipine Controlled-release Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Nifedipine Controlled-release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Nifedipine Controlled-release Tablets Sales by Country (2020-2025) & (kg)
Table 47. Middle East and Africa Nifedipine Controlled-release Tablets Sales by Country (2026-2031) & (kg)
Table 48. Middle East and Africa Nifedipine Controlled-release Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Nifedipine Controlled-release Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Nifedipine Controlled-release Tablets Sales (kg) by Type (2020-2025)
Table 51. Global Nifedipine Controlled-release Tablets Sales (kg) by Type (2026-2031)
Table 52. Global Nifedipine Controlled-release Tablets Sales Market Share by Type (2020-2025)
Table 53. Global Nifedipine Controlled-release Tablets Sales Market Share by Type (2026-2031)
Table 54. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Nifedipine Controlled-release Tablets Revenue Market Share by Type (2020-2025)
Table 57. Global Nifedipine Controlled-release Tablets Revenue Market Share by Type (2026-2031)
Table 58. Global Nifedipine Controlled-release Tablets Price (US$/g) by Type (2020-2025)
Table 59. Global Nifedipine Controlled-release Tablets Price (US$/g) by Type (2026-2031)
Table 60. Global Nifedipine Controlled-release Tablets Sales (kg) by Application (2020-2025)
Table 61. Global Nifedipine Controlled-release Tablets Sales (kg) by Application (2026-2031)
Table 62. Global Nifedipine Controlled-release Tablets Sales Market Share by Application (2020-2025)
Table 63. Global Nifedipine Controlled-release Tablets Sales Market Share by Application (2026-2031)
Table 64. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Nifedipine Controlled-release Tablets Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Nifedipine Controlled-release Tablets Revenue Market Share by Application (2020-2025)
Table 67. Global Nifedipine Controlled-release Tablets Revenue Market Share by Application (2026-2031)
Table 68. Global Nifedipine Controlled-release Tablets Price (US$/g) by Application (2020-2025)
Table 69. Global Nifedipine Controlled-release Tablets Price (US$/g) by Application (2026-2031)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 73. Bayer Nifedipine Controlled-release Tablets Product
Table 74. Bayer Recent Developments/Updates
Table 75. Shanghai Shyndec Pharmaceutical Company Information
Table 76. Shanghai Shyndec Pharmaceutical Description and Business Overview
Table 77. Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 78. Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 79. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
Table 80. Beijing Honglin Pharma Company Information
Table 81. Beijing Honglin Pharma Description and Business Overview
Table 82. Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 83. Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product
Table 84. Beijing Honglin Pharma Recent Developments/Updates
Table 85. Nanjing Easeheal Pharmaceutical Company Information
Table 86. Nanjing Easeheal Pharmaceutical Description and Business Overview
Table 87. Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 88. Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 89. Nanjing Easeheal Pharmaceutical Recent Developments/Updates
Table 90. Qingdao BAHEAL Pharmaceutical Company Information
Table 91. Qingdao BAHEAL Pharmaceutical Description and Business Overview
Table 92. Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 93. Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 94. Qingdao BAHEAL Pharmaceutical Recent Developments/Updates
Table 95. Simcere Pharmaceutical Company Information
Table 96. Simcere Pharmaceutical Description and Business Overview
Table 97. Simcere Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 98. Simcere Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 99. Simcere Pharmaceutical Recent Developments/Updates
Table 100. Hefei Lifeon Pharmaceutical Company Information
Table 101. Hefei Lifeon Pharmaceutical Description and Business Overview
Table 102. Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 103. Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 104. Hefei Lifeon Pharmaceutical Recent Developments/Updates
Table 105. China Resources Double-Crane Pharmaceutical Company Information
Table 106. China Resources Double-Crane Pharmaceutical Description and Business Overview
Table 107. China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 108. China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 109. China Resources Double-Crane Pharmaceutical Recent Developments/Updates
Table 110. CSPC Ouyi Pharmaceutical Company Information
Table 111. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 112. CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 113. CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 114. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 115. ApicHope Pharmaceutical Company Information
Table 116. ApicHope Pharmaceutical Description and Business Overview
Table 117. ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 118. ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Product
Table 119. ApicHope Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Nifedipine Controlled-release Tablets Distributors List
Table 123. Nifedipine Controlled-release Tablets Customers List
Table 124. Nifedipine Controlled-release Tablets Market Trends
Table 125. Nifedipine Controlled-release Tablets Market Drivers
Table 126. Nifedipine Controlled-release Tablets Market Challenges
Table 127. Nifedipine Controlled-release Tablets Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nifedipine Controlled-release Tablets
Figure 2. Global Nifedipine Controlled-release Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nifedipine Controlled-release Tablets Market Share by Type: 2024 & 2031
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Nifedipine Controlled-release Tablets Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Nifedipine Controlled-release Tablets Market Share by Application: 2024 & 2031
Figure 8. Hypertension
Figure 9. Coronary Heart Disease
Figure 10. Chronic Stable Angina
Figure 11. Other
Figure 12. Global Nifedipine Controlled-release Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Nifedipine Controlled-release Tablets Market Size (2020-2031) & (US$ Million)
Figure 14. Global Nifedipine Controlled-release Tablets Sales (2020-2031) & (kg)
Figure 15. Global Nifedipine Controlled-release Tablets Average Price (US$/g) & (2020-2031)
Figure 16. Nifedipine Controlled-release Tablets Report Years Considered
Figure 17. Nifedipine Controlled-release Tablets Sales Share by Manufacturers in 2024
Figure 18. Global Nifedipine Controlled-release Tablets Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Nifedipine Controlled-release Tablets Players: Market Share by Revenue in Nifedipine Controlled-release Tablets in 2024
Figure 20. Nifedipine Controlled-release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Nifedipine Controlled-release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Nifedipine Controlled-release Tablets Sales Market Share by Country (2020-2031)
Figure 23. North America Nifedipine Controlled-release Tablets Revenue Market Share by Country (2020-2031)
Figure 24. United States Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Nifedipine Controlled-release Tablets Sales Market Share by Country (2020-2031)
Figure 27. Europe Nifedipine Controlled-release Tablets Revenue Market Share by Country (2020-2031)
Figure 28. Germany Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Nifedipine Controlled-release Tablets Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Nifedipine Controlled-release Tablets Revenue Market Share by Region (2020-2031)
Figure 35. China Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Nifedipine Controlled-release Tablets Sales Market Share by Country (2020-2031)
Figure 43. Latin America Nifedipine Controlled-release Tablets Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Nifedipine Controlled-release Tablets Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Nifedipine Controlled-release Tablets Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Nifedipine Controlled-release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Nifedipine Controlled-release Tablets by Type (2020-2031)
Figure 54. Global Revenue Market Share of Nifedipine Controlled-release Tablets by Type (2020-2031)
Figure 55. Global Nifedipine Controlled-release Tablets Price (US$/g) by Type (2020-2031)
Figure 56. Global Sales Market Share of Nifedipine Controlled-release Tablets by Application (2020-2031)
Figure 57. Global Revenue Market Share of Nifedipine Controlled-release Tablets by Application (2020-2031)
Figure 58. Global Nifedipine Controlled-release Tablets Price (US$/g) by Application (2020-2031)
Figure 59. Nifedipine Controlled-release Tablets Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
